Barclays’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-104,822
| Closed | -$1.01M | – | 4659 |
|
|
2024
Q4 | $1.01M | Sell |
104,822
-15,642
| -13% | -$150K | ﹤0.01% | 2633 |
|
|
2024
Q3 | $345K | Buy |
120,464
+68,688
| +133% | +$197K | ﹤0.01% | 3195 |
|
|
2024
Q2 | $151K | Sell |
51,776
-23,569
| -31% | -$68.7K | ﹤0.01% | 3193 |
|
|
2024
Q1 | $240K | Sell |
75,345
-45,992
| -38% | -$147K | ﹤0.01% | 3240 |
|
|
2023
Q4 | $408K | Buy |
121,337
+75,795
| +166% | +$255K | ﹤0.01% | 3119 |
|
|
2023
Q3 | $109K | Buy |
45,542
+13,174
| +41% | +$31.5K | ﹤0.01% | 3301 |
|
|
2023
Q2 | $57K | Sell |
32,368
-70,177
| -68% | -$124K | ﹤0.01% | 3619 |
|
|
2023
Q1 | $316K | Buy |
102,545
+44,436
| +76% | +$137K | ﹤0.01% | 2914 |
|
|
2022
Q4 | $308K | Buy |
58,109
+26,650
| +85% | +$141K | ﹤0.01% | 2879 |
|
|
2022
Q3 | $111K | Buy |
31,459
+1,858
| +6% | +$6.56K | ﹤0.01% | 3385 |
|
|
2022
Q2 | $76K | Sell |
29,601
-4,498
| -13% | -$11.5K | ﹤0.01% | 3578 |
|
|
2022
Q1 | $152K | Buy |
+34,099
| New | +$152K | ﹤0.01% | 3474 |
|